FROG.NASDAQJfrog LTD

Form 4: JFrog's CTO, Yoav Landman, Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Yoav Landman, Chief Technology Officer of JFrog Ltd, executed sales of ordinary shares on May 8, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Yoav Landman, the Chief Technology Officer of JFrog Ltd, reported the sale of ordinary shares on May 8, 2025.
  • The sales were conducted under a Rule 10b5-1 trading plan adopted on August 13, 2024.
  • A total of 16,932 shares were sold at a weighted average price of $35.28, and 3,068 shares were sold at a weighted average price of $35.62.
  • Following these transactions, Landman beneficially owns 6,416,901 ordinary shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing trading plan, with no explicit positive or negative implications.

Industry Context

Executive share sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on insider information at the time of the transaction.

Stakeholder Impact

  • The share sales by a top executive could potentially create short-term uncertainty among shareholders, although the existence of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

DateDescription
08/13/2024Date the Reporting Person adopted a Rule 10b5-1 trading plan
05/08/2025Date of the reported transactions (sale of ordinary shares)
05/12/2025Date of signature for the Form 4 filing

Keywords

Form 4, Yoav Landman, JFrog, Share Sale, 10b5-1 Trading Plan, Beneficial Ownership, Ordinary Shares, CTO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.